Tech Investors

CureDuchenne Ventures

CureDuchenne Ventures is an investing group that backs qaulifying tech sector companies.

Venture Investor Overview

Contact Information

Background Information

Overview

CureDuchenne launched CureDuchenne Ventures, an initiative to identify and fund a robust pipeline of therapies to treat Duchenne, the most common and lethal form of muscular dystrophy. CureDuchenne Ventures funding strategy includes identifying drug targets and programs that exhibit the potential to advance rapidly to proof of concept studies. The goal of CureDuchenne Ventures is to provide substantial funding to several research projects over the next three years that will serve as a catalyst to drive significant investment from biotech and pharmaceutical companies and venture philanthropists.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/11/2023

Transaction History

Our records indicate that CureDuchenne Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Founder

Paul Miller

        

Founder

Debra Miller

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

CureDuchenne Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more tech investors:

CU Healthcare Innovation Fund | Cuyahoga County North Coast Opportunities Fund

Share this article

About Our Tech Investor Database

Our tech investing data comes from VentureDeal.com, a leading provider of tech investor transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary